Healthcare
Biocon's Q4 Profit Drops 56.8% with Full-Year Profit Also Down Significantly
This news covers Biocon's financial performance for the fourth quarter of the fiscal year. The company has reported a substantial 56.8% drop in its net profit for the January-March period. This decrease, bringing the quarterly profit to ₹198.6 crore, was partly attributed to an exceptional expense of ₹80.4 crore. Looking at the full financial year's results, Biocon's profit also saw a significant decline, standing at ₹368.8 crore compared to the previous year. Investors and market watchers will be closely examining these results for insights into the pharmaceutical sector's current dynamics within the Indian stock market. The report falls under the 'Results' category, reflecting a potentially negative trajectory for the company's recent financial outcomes.
More in Healthcare
Nifty
Nifty 50 Today: Adani Ent Leads Gains While HDFC Life Falls (25th Aug '26)
- Adani Enterprises led the Nifty 50 gainers with a 3.72% le, followed by Max Health at 2.5%
- Apollo Hospitals gained 2.15%, while IndiGo and Adani Ports rose 2.01% and 1.83%
- HDFC Life was the biggest laggard, falling upto 1.13%, followed by Cipla and ONGC
Healthcare
Manipal Health Bets on Organic Growth After Landmark IPO Launch
- Manipal plans to add nearly 3,000 beds through greenfield and brownfield projects.
- Most IPO proceeds will repay debt, helping the hospital chain become nearly debt free.
- Management says future growth will focus on expansion before pursuing large acquisitions.